Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium
- PMID: 7923141
Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium
Abstract
Although several tyrosine kinase-type growth factor receptors have been demonstrated in human colonic epithelial cells, the full spectrum of growth factor receptors has not been identified. Low stringency screening of a complementary DNA library prepared from the human colon cancer-derived cell line HT-29 with a probe containing the tyrosine kinase domain of human c-src kinase led to the identification and isolation of a clone containing a receptor class tyrosine kinase. This putative receptor was found to be identical to the human fibroblast growth factor receptor 3 (FGFR3) except for a region of 150 nucleotides (50 amino acids) encoding the presumptive ligand-binding domain, where it exhibited only 32% homology with the previously described FGFR3. The variant domain corresponded precisely to the splicing junctions of the exon encoding the carboxyl terminal half of the third immunoglobulin-like domain, suggesting that two forms of FGFR3 result from splicing of alternate exons in a manner similar to that previously found for FGFR1 and FGFR2. By prior convention, the previously reported from of FGFR3 was designated IIIc due to its high degree of homology with the IIIc domain of FGFR1 (83% homology) and the IIIc domain of FGFR2 (81% homology). However, the ligand-binding domain of FGFR3 found in the HT-29 cell line was more highly divergent from all previously reported FGFR immunoglobulin-like domain IIIs than any other two members of this receptor family. Therefore, we propose to designate the newly reported form as the FGFR3 IIIb variant. Genomic polymerase chain reaction confirmed that the IIIb-containing exon occupies a position 5' relative to the IIIc-containing exon within the FGFR3 gene. Northern blot analysis using a probe encompassing sequences unique to the FGFR3 IIIb mRNA confirmed the expression of a 4.4-kilobase transcript in two colon cancer-derived cell lines as well as normal human colonic mucosa. Using a technique combining reverse transcriptase polymerase chain reaction with restriction endonuclease digestion, cell lines, primary cells, and tissues were assessed for IIIb and IIIc transcripts; expression of the IIIb variant was associated with an epithelial lineage, while the IIIc variant was expressed predominantly in nonepithelial cells and tissues.
Similar articles
-
Expression of fibroblast growth factor receptor-2 splice variants is developmentally and tissue-specifically regulated in the amphibian embryo.Dev Biol. 1994 Jul;164(1):173-82. doi: 10.1006/dbio.1994.1189. Dev Biol. 1994. PMID: 8026621
-
Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.Cancer Res. 2005 Nov 15;65(22):10441-9. doi: 10.1158/0008-5472.CAN-05-1718. Cancer Res. 2005. PMID: 16288035
-
Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.Biochem Biophys Res Commun. 2000 Jan 19;267(2):658-62. doi: 10.1006/bbrc.1999.2010. Biochem Biophys Res Commun. 2000. PMID: 10631118
-
Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.Exp Cell Res. 2005 Apr 1;304(2):417-31. doi: 10.1016/j.yexcr.2004.11.012. Epub 2004 Dec 16. Exp Cell Res. 2005. PMID: 15748888 Review.
-
Fibroblast growth factor receptors, developmental corruption and malignant disease.Carcinogenesis. 2013 Oct;34(10):2198-205. doi: 10.1093/carcin/bgt254. Epub 2013 Jul 23. Carcinogenesis. 2013. PMID: 23880303 Review.
Cited by
-
Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.J Nucleic Acids. 2012;2012:950508. doi: 10.1155/2012/950508. Epub 2011 Dec 12. J Nucleic Acids. 2012. PMID: 22203889 Free PMC article.
-
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.Br J Cancer. 2003 Oct 6;89(7):1276-84. doi: 10.1038/sj.bjc.6601249. Br J Cancer. 2003. PMID: 14520460 Free PMC article.
-
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.Mol Biol Cell. 2006 Feb;17(2):576-84. doi: 10.1091/mbc.e05-04-0368. Epub 2005 Nov 16. Mol Biol Cell. 2006. PMID: 16291864 Free PMC article.
-
Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling.Cancers (Basel). 2021 Sep 29;13(19):4891. doi: 10.3390/cancers13194891. Cancers (Basel). 2021. PMID: 34638374 Free PMC article. Review.
-
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).Expert Rev Mol Med. 2010 Mar 25;12:e10. doi: 10.1017/S1462399410001407. Expert Rev Mol Med. 2010. PMID: 20334706 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous